Tablo Sales Boost Outset Bottom Line
Product revenues increased 5.5% and service revenues increased in Q3 of 2022 over 2021. The Tablo is used for acute and home HD, and Outset won a 5-year VA contract for Tablo in hospitals and homes.
Read the full article » | Posted 12-19-2022
Related Articles
- Update on H.R. 8875 “Improving Home Dialysis Act of 2026.” Posted 07-16-2026
- Stickman Industries Offers Many Products for Home Dialysis Patients Posted 07-16-2026
- Who Qualifies for Home Dialysis? Posted 07-16-2026
- NxStage’s ICan Tool Can Help HD Patients Learn to Self-cannulate Posted 07-16-2026

